|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (K.M.S.)
µ-Opioid receptors have been shown to contribute to orphanin
FQ/nociceptin (OFQ/N)-mediated analgesia and hyperalgesia, indicating that
both pro- and antinociceptive actions of OFQ/N are influenced by µ-opioid
receptors. A 60-min activation of µ-or opioid receptor-like 1 (ORL1) opioid
receptors natively expressed in BE(2)-C human neuroblastoma cells desensitized
both µ- and ORL1 receptor-mediated inhibition of cAMP accumulation. The
mechanism(s) of OFQ/N-mediated µ- and ORL1 cross talk involves the
conventional protein kinase C isozyme, PKC-
, and G protein-coupled
receptor kinases (GRKs) 2 and 3. Unlike OFQ/N-mediated desensitization of ORL1
and µ-opioid receptors,
[D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin
(DAMGO)-mediated ORL1 desensitization in BE(2)-C cells is PKC-independent.
However, DAMGO (1 µM) pretreatment increased membrane levels of GRK2 and
GRK3, indicating their translocation to the membrane upon activation. This
suggests that DAMGO activation of µ-opioid receptors results in GRK2 and
GRK3 inactivation of ORL1 upon challenge with OFQ/N. Antisense, but not sense,
DNA selectively targeting GRK2 or GRK3 blocks DAMGO-mediated µ- and ORL1
desensitization, respectively. However, in SH-SY5Y neuroblastoma cells, DAMGO
failed to desensitize ORL1 or alter membrane PKC-
or GRK levels.
Instead, DAMGO stimulated PKC-
translocation to the cell membrane and
produced µ-receptor desensitization. These results indicate that acute
exposure to µ-receptor agonists can regulate ORL1 function, but the ability
to do so varies from cell type to cell type. These results also confirm the
existence of multiple signaling mechanisms for µ-opioid receptors and the
importance of these mechanisms for µ-receptor-mediated-heterologous
effects.
Address correspondence to: Dr. Kelly M. Standifer, Department of Pharmacological and Pharmaceutical Sciences, 521 Science and Research 2, University of Houston, Houston, TX 77204-5037. E-mail standifer{at}uh.edu
This article has been cited by other articles:
![]() |
H. Z. Ozsoy, D. R. Thakker, and K. M. Standifer Orphanin FQ/Nociceptin Potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin-Induced {micro}-Opioid Receptor Phosphorylation Mol. Pharmacol., August 1, 2005; 68(2): 447 - 456. [Abstract] [Full Text] [PDF] |
||||